The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Cosmo Pharmaceuticals NV's share price is CHF70.50.
Cosmo Pharmaceuticals NV's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was CHF6.30. Hence, Cosmo Pharmaceuticals NV's PS Ratio for today is 11.19.
Warning Sign:
Cosmo Pharmaceuticals NV stock PS Ratio (=11.77) is close to 1-year high of 11.77
The historical rank and industry rank for Cosmo Pharmaceuticals NV's PS Ratio or its related term are showing as below:
CHIX:COPNz'
s PS Ratio Range Over the Past 10 Years
Min: 5.52 Med: 19.08 Max: 39.89
Current: 11.36
During the past 13 years, Cosmo Pharmaceuticals NV's highest PS Ratio was 39.89. The lowest was 5.52. And the median was 19.08.
CHIX:COPNz's PS Ratio is ranked worse than 89.74% of 1004
companies
in the Drug Manufacturers industry
Industry Median: 2.21
vs CHIX:COPNz: 11.36
During the past 12 months, the average Revenue per Share Growth Rate of Cosmo Pharmaceuticals NV was 38.80% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 9.60% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 0.20% per year.
During the past 10 years, the average Revenue per Share Growth Rate was -0.90% per year.
During the past 13 years, Cosmo Pharmaceuticals NV's highest 3-Year average Revenue per Share Growth Rate was 32.00% per year. The lowest was -28.20% per year. And the median was -1.75% per year.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Cosmo Pharmaceuticals NV's PS Ratio
For the Drug Manufacturers - General subindustry, Cosmo Pharmaceuticals NV's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cosmo Pharmaceuticals NV's PS Ratio Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Cosmo Pharmaceuticals NV's PS Ratio distribution charts can be found below:
* The bar in red indicates where Cosmo Pharmaceuticals NV's PS Ratio falls into.
Cosmo Pharmaceuticals NV PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Cosmo Pharmaceuticals NV's Share Price of today is CHF70.50.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cosmo Pharmaceuticals NV's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was CHF6.30.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Cosmo Pharmaceuticals NV (CHIX:COPNz) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Cosmo Pharmaceuticals NV PS Ratio Related Terms
Thank you for viewing the detailed overview of Cosmo Pharmaceuticals NV's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Cosmo Pharmaceuticals NV (CHIX:COPNZ) Business Description
Cosmo Pharmaceuticals NV is a pharmaceutical company with a focus on gastrointestinal diseases, dermatology and healthtech. The company develops and manufactures products that are distributed globally by its partners. Products that the company has developed include Lialda/Mezavant/Mesavancol and Uceris/Cortiment, for the treatment of ulcerative colitis; GI Genius, which uses artificial intelligence to aid the detection of colorectal polyps during colonoscopy; Eleview, a submucosal injectable composition for use in gastrointestinal endoscopic procedures; Aemcolo for the treatment of travellers' diarrhoea (TD) and Winlevi for the treatment of acne. Product pipeline includes Breezula, GI Genius, Methylene blue MMX, Aemcolo, CB-03-10 and CB-01-33.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CHIX:COPNZ has been successfully added to your 